Phibro Animal Health Stock News

Phibro Animal Health Corp (NASDAQ: PAHC ) and Dyadic International Inc (NASDAQ: DYAI ) have entered into an exclusive license agreement for a Phibro targeted disease. Dyadic granted Phibro an exclusive license for its proprietary C1 -cell protein production platform to produce specific targeted antigens for developing and commercializing a poultry vaccine for … Full story available on Benzinga.com

Phibro Animal Health Corporation (PAHC) CEO Jack Bendheim on Q2 2022 Results - Earnings Call Transcript

Phibro Animal Health Corp PAHC and Dyadic International Inc DYAI have entered into an exclusive license agreement for a Phibro targeted disease.  Get the Inside Access Traders Are Using to Profi

Phibro Animal Health <> said that the FDA issued a notice in the Federal Register announcing its plans to hold a public hearing on Mecadox (carbadox), a treatment for

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its second quarter financial results on Wednesday, February 9, 2022, after the market closes. Phibro

Investors are optimistic about Phibro (PAHC), given robust performance by its nutritional specialties and vaccine product lines.

Investors are optimistic about Phibro (PAHC), given robust performance by its nutritional specialties and vaccine product lines.

Though Phirbo (PAHC) has raised prices on selective products, these increases do not fully compensate for the higher cost of freight and labor materials.

Though Phirbo (PAHC) has raised prices on selective products, these increases do not fully compensate for the higher cost of freight and labor materials.

Parametric Portfolio Associates LLC boosted its stake in Phibro Animal Health Co. (NASDAQ:PAHC) by 0.9% in the second quarter, HoldingsChannel reports. The firm owned 85,760 shares of the companys stock after acquiring an additional 735 shares during the period. Parametric Portfolio Associates LLCs holdings in Phibro Animal Health were worth $2,477,000 at the end of []

Nisa Investment Advisors LLC boosted its holdings in Phibro Animal Health Co. (NASDAQ:PAHC) by 187.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 8,899 shares of the companys stock after buying an additional 5,799 shares during the quarter. Nisa Investment Advisors LLCs holdings in []

Phibro Animal Health Co. (NASDAQ:PAHC) shares traded down 4.2% during mid-day trading on Wednesday . The company traded as low as $20.48 and last traded at $20.48. 582 shares changed hands during trading, a decline of 100% from the average session volume of 121,549 shares. The stock had previously closed at $21.38. Separately, Morgan Stanley []

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Marshall Wace LLP decreased its position in Phibro Animal Health Co. (NASDAQ:PAHC) by 54.8% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 20,639 shares of the companys stock after selling 25,053 shares during the period. Marshall Wace LLP owned about 0.05% of Phibro Animal Health worth []